Diabetes is rapidly increasing in India, affecting over 101 million people, often manifesting differently than in the West. Indians tend to...

India faces a significant diabetes crisis, with millions undiagnosed, increasing the risk of heart disease. Early detection through screeni...

A Lancet Global Health study reveals that nearly 40% of Indian diabetics are unaware of their condition, with a 20% prevalence among adults...

Zerodha CEO Nithin Kamath raises concern about the increasing number of diabetes cases in India. He highlights the alarming statistics and ...

A new study reveals that over 800 million adults worldwide have diabetes. India leads the world with 212 million cases, followed by China w...

India has the highest global prevalence of diabetes, with 212 million adults diagnosed in 2022, surpassing China and the United States. A n...

Statistics show low treatment target compliance among Indian diabetes patients, increasing heart disease risks. Timely screening and weight...

India experiences a surge in Rybelsus sales, impacting the anti-obesity market. Semaglutide dominates, reflecting India's obesity challenge...

India is the 'diabetes capital of the world', according to a study by the Indian Council of Medical Research that shows the country now has...

A few almonds 30 mins before breakfast, lunch, and dinner throughout the study duration.

The age profile of people dying of Covid-19 has changed with 48.8% of people under the age of 60 years dying in India within a month. Accor...

With more than 70 million people diagnosed with the disease, India has the second largest population with diabetes in the world.

Ashok Jain began diabetes management clinics across India to help other diabetics lead a healthier and longer life.

Adani Wilmar, manufacturer and distributor of cooking oils, launched India’s first diabetes care oil by the name Fortune VIVO on Monday.

It aims to reverse diabesity by building next-generation diagnostics and evidence-based lifestyle coaching programmes for diabetics.

The move will drastically reduce prices of key drugs, but at the same time, jeopardise the plans of multinational drug companies.

Maharashtra recorded the lowest prevalence of diabetes (2.5%) on one hand but the highest prevalence of people suffering from high BP (18%)...